Document Detail


An economic evaluation of antihypertensive therapies based on clinical trials.
MedLine Citation:
PMID:  22249479     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Hypertension is a major issue in public health, and the financial costs associated with hypertension continue to increase. Cost-effectiveness studies focusing on antihypertensive drug combinations, however, have been scarce. The cost-effectiveness ratios of the traditional treatment (hydrochlorothiazide and atenolol) and the current treatment (losartan and amlodipine) were evaluated in patients with grade 1 or 2 hypertension (HT1-2). For patients with grade 3 hypertension (HT3), a third drug was added to the treatment combinations: enalapril was added to the traditional treatment, and hydrochlorothiazide was added to the current treatment.
METHODS: Hypertension treatment costs were estimated on the basis of the purchase prices of the antihypertensive medications, and effectiveness was measured as the reduction in systolic blood pressure and diastolic blood pressure (in mm Hg) at the end of a 12-month study period.
RESULTS: When the purchase price of the brand-name medication was used to calculate the cost, the traditional treatment presented a lower cost-effectiveness ratio [US$/mm Hg] than the current treatment in the HT1-2 group. In the HT3 group, however, there was no difference in cost-effectiveness ratio between the traditional treatment and the current treatment. The cost-effectiveness ratio differences between the treatment regimens maintained the same pattern when the purchase price of the lower-cost medication was used.
CONCLUSIONS: We conclude that the traditional treatment is more cost-effective (US$/mm Hg) than the current treatment in the HT1-2 group. There was no difference in cost-effectiveness between the traditional treatment and the current treatment for the HT3 group.
Authors:
Rosana Lima Garcia Tsuji; Giovanio Vieira da Silva; Katia Coelho Ortega; Otavio Berwanger; Decio Mion Júnior
Related Documents :
23886859 - Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure i...
9084899 - Decreased cholecystokinin levels in cerebrospinal fluid of patients with adult chronic ...
16530979 - Theoretical considerations on the pathophysiology of normal pressure hydrocephalus (nph...
1320159 - Cardiovascular responses to intracerebroventricular infusion of artificial cerebrospina...
19513309 - Pneumocephalus in patients with orthostatic headache.
17101909 - Csf opening pressure: reference interval and the effect of body mass index.
21800889 - Pressure-dependent ion current rectification in conical-shaped glass nanopores.
18282059 - In situ high-pressure x-ray diffraction study of h2o ice vii.
2366949 - Effect of adenosine on isolated and superfused cat carotid body activity.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinics (São Paulo, Brazil)     Volume:  67     ISSN:  1980-5322     ISO Abbreviation:  Clinics (Sao Paulo)     Publication Date:  2012  
Date Detail:
Created Date:  2012-01-17     Completed Date:  2012-09-19     Revised Date:  2013-06-26    
Medline Journal Info:
Nlm Unique ID:  101244734     Medline TA:  Clinics (Sao Paulo)     Country:  Brazil    
Other Details:
Languages:  eng     Pagination:  41-8     Citation Subset:  IM    
Affiliation:
Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Nephrology Division, Hypertension Unit, Brazil. rosanatsuji@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amlodipine / adverse effects,  economics*
Antihypertensive Agents / adverse effects,  economics*
Atenolol / adverse effects,  economics*
Blood Pressure / drug effects
Drug Costs
Drug Therapy, Combination / economics
Enalapril / administration & dosage,  economics
Female
Humans
Hydrochlorothiazide / adverse effects,  economics*
Hypertension / classification,  drug therapy*
Losartan / adverse effects,  economics*
Male
Middle Aged
Randomized Controlled Trials as Topic
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 114798-26-4/Losartan; 29122-68-7/Atenolol; 58-93-5/Hydrochlorothiazide; 75847-73-3/Enalapril; 88150-42-9/Amlodipine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Regulation of hypoxia-inducible factor-1? (HIF-1?) expression by interleukin-1? (IL-1 ?), insulin-li...
Next Document:  Hemodynamic responses and upper airway morbidity following tracheal intubation in patients with hype...